Home » Market News » DirectorsTalk Highlights » Signs of Lupus in Women
Immupharma Plc

Signs of Lupus in Women

Anyone can have lupus, but the fact is that women have more than their fair share of this autoimmune condition. In the U.S., an estimated 1 million to 1.5 million people have lupus, and women account for about 90% of lupus diagnoses.

Facial rashes, persistent fatigue and joint pain are more familiar lupus symptoms. However, with systemic lupus erythematosus, the most common and serious form, inflammation flare-ups and symptoms may involve multiple organs including the brain, heart and kidneys.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.